Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

809
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
809
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.2K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.1K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.1K
Seizures: Classification01:13

Seizures: Classification

641
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
641
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

57.1K
Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
57.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct evidence of upper motor neuron excitability changes in a patient with ALS.

Journal of neurophysiology·2026
Same author

Improvement of Refractory Restless Legs Syndrome in a Parkinson's Disease Patient After Semaglutide Treatment: A Novel Clinical Observation.

Journal of movement disorders·2026
Same author

Clinical and Neuroimaging Predictors of Posterior Circulation Stroke: A Retrospective Analysis of In-Hospital Features.

Brain sciences·2026
Same author

Functional Neurological Disorder during Foscarbidopa/Foslevodopa Infusion in PRKN-Associated Parkinsonism.

Movement disorders clinical practice·2026
Same author

Depressive symptoms as independent correlates of epilepsy-related cognitive burden.

Epilepsia·2026
Same author

Cellular and Molecular Mechanisms of Non-Invasive Brain Stimulation Techniques: A Systematic Review on the Implications for the Treatment of Neurological Disorders.

Cells·2025

Related Experiment Video

Updated: Oct 2, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.5K

Classification of Dystonia.

Lazzaro di Biase1,2,3, Alessandro Di Santo1,2, Maria Letizia Caminiti1,2

  • 1Neurology Unit, Campus Bio-Medico University Hospital Foundation, Via Álvaro del Portillo 200, 00128 Rome, Italy.

Life (Basel, Switzerland)
|February 25, 2022
PubMed
Summary

Dystonia, a movement disorder causing abnormal postures from muscle contractions, is often misdiagnosed due to its varied symptoms. This review details its classification and phenomenology for accurate diagnosis and treatment.

Keywords:
classificationclinical diagnosisdystoniaetiology

More Related Videos

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

9.9K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K

Related Experiment Videos

Last Updated: Oct 2, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.5K
Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
10:05

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia

Published on: January 27, 2018

9.9K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K

Area of Science:

  • Neurology
  • Movement Disorders
  • Clinical Diagnosis

Background:

  • Dystonia is a hyperkinetic movement disorder defined by involuntary muscle contractions leading to abnormal postures.
  • Its broad clinical spectrum frequently results in underdiagnosis or misdiagnosis.
  • Accurate phenomenological description via physical examination is crucial for diagnosis.

Purpose of the Study:

  • To delineate the diverse phenomenological spectrum of dystonia.
  • To present the latest approved classification system for dystonia.
  • To incorporate emerging knowledge in the field.

Main Methods:

  • Review of clinical characteristics and etiology-based classification of dystonia.
  • Analysis of diagnostic challenges and proposed classification systems.
  • Synthesis of current understanding and recent advancements.

Main Results:

  • The current dystonia classification includes Axis I (clinical characteristics) and Axis II (etiology).
  • This classification aids movement disorder specialists in accurate characterization.
  • Understanding the phenomenological spectrum is key to effective treatment.

Conclusions:

  • Accurate diagnosis of dystonia relies on detailed phenomenological assessment.
  • The established classification system provides a framework for diagnosis and treatment guidance.
  • Ongoing research continues to expand knowledge on dystonia.